A Bayesian dose-finding design for drug combination trials with delayed toxicities
type: Item
instance of: scholarly article
title: A Bayesian dose-finding design for drug combination trials with delayed toxicities
zbMATH Open document ID: 1329.62431
DOI: 10.1214/13-BA839
author: Suyu Liu
author: Jing Ning
published in: Bayesian Analysis
publication date: 2016-02-02T00:00:00Z
full work available at URL: https://projecteuclid.org/euclid.ba/1378729925
Mathematics Subject Classification ID: 62P10
Mathematics Subject Classification ID: 62D05
Mathematics Subject Classification ID: 62F15
Mathematics Subject Classification ID: 62F35
Mathematics Subject Classification ID: 62K05
Mathematics Subject Classification ID: 62L05
Mathematics Subject Classification ID: 92C50
zbMATH DE Number: 6538672
zbMATH Keywords: adaptive design
zbMATH Keywords: late-onset toxicity
zbMATH Keywords: combining drugs
zbMATH Keywords: missing data
zbMATH Keywords: maximum tolerated dose
zbMATH Keywords: phase I trial
Wikidata QID: Q39125629
MaRDI profile type: Publication
Recommended article: Bayesian Dose-Finding in Phase I/II Clinical Trials Using Toxicity and Efficacy Odds Ratios
Recommended article: Bayesian Dose-Finding in Two Treatment Cycles Based on the Joint Utility of Efficacy and Toxicity
Recommended article: Adaptive Bayesian compound designs for dose finding studies
Recommended article: Adaptive Bayesian phase I clinical trial designs for estimating the maximum tolerated doses for two drugs while fully utilizing all toxicity information
Recommended article: Bayesian dose finding for combined drugs with discrete and continuous doses
Recommended article: Bayesian design for clinical trials with a constraint on the total available dose
Recommended article: Bayesian phase II adaptive randomization by jointly modeling time-to-event efficacy and binary toxicity
Recommended article: Q4389808
description: scientific article; zbMATH DE number 6538672